Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypereosinophilia.

B J Bain1

  • 1Department of Haematology, St Mary's Hospital, Campus of Imperial College School of Medicine, London, United Kingdom. b.bain@ic.ac.uk

Current Opinion in Hematology
|December 23, 1999
PubMed
Summary
This summary is machine-generated.

New research clarifies hypereosinophilic syndromes and eosinophilic leukemia, identifying leukemogenic mechanisms and the role of T lymphocytes. Treatment options like chemotherapy and bone marrow transplant are also better defined.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Macropolycytes: Severe stress time for neutrophils.

Morphologie : bulletin de l'Association des anatomistes·2020
Same author

The Haematologist and the Infective Complications of HIV Infection.

Hematology (Amsterdam, Netherlands)·2016
Same author

An unexpectedly bizarre blood film in hemoglobin H disease.

American journal of hematology·2012
Same author

[Clarification of possible anemia].

Praxis·2009
Same author

Neonatal/newborn haemoglobinopathy screening in Europe and Africa.

Journal of clinical pathology·2008
Same author

Haemoglobin A2' and its significance in beta thalassaemia diagnosis.

International journal of laboratory hematology·2008
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Hypereosinophilia diagnosis is challenging, particularly differentiating eosinophilic leukemia from idiopathic hypereosinophilic syndromes.
  • Understanding the underlying mechanisms of these conditions is crucial for effective treatment.

Purpose of the Study:

  • To identify leukemogenic mechanisms in eosinophilic leukemia subtypes.
  • To elucidate the role of T lymphocyte clones in unexplained eosinophilia.
  • To further define therapeutic options for eosinophilic leukemia and idiopathic hypereosinophilic syndromes.

Main Methods:

  • Review of recent advances in understanding hypereosinophilia.
  • Identification of leukemogenic mechanisms in eosinophilic leukemia.
  • Elucidation of T lymphocyte involvement in eosinophilia.

Related Experiment Videos

Main Results:

  • Leukemogenic mechanisms identified in specific eosinophilic leukemia subtypes.
  • The role of T lymphocyte clones in causing unexplained eosinophilia has been clarified.
  • Therapeutic roles of chemotherapy, interferon, and bone marrow transplantation have been further defined.

Conclusions:

  • Distinguishing eosinophilic leukemia from idiopathic hypereosinophilic syndromes is improving.
  • T lymphocytes play a significant role in certain types of eosinophilia.
  • Treatment strategies for eosinophilic leukemia and idiopathic hypereosinophilic syndromes are becoming more defined.